Cargando…
Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody
BACKGROUND: Distinct clinical presentations of interstitial lung disease (ILD) with the myositis-specific antibodies, including anti-synthetase antibodies, are well-recognized. However, the association between ILD and the myositis-associated antibodies, including anti-Ro52, is less established. Our...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852961/ https://www.ncbi.nlm.nih.gov/pubmed/31718649 http://dx.doi.org/10.1186/s12931-019-1231-7 |